0001209191-15-056210.txt : 20150625
0001209191-15-056210.hdr.sgml : 20150625
20150625143042
ACCESSION NUMBER: 0001209191-15-056210
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150618
FILED AS OF DATE: 20150625
DATE AS OF CHANGE: 20150625
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZS Pharma, Inc.
CENTRAL INDEX KEY: 0001459266
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263305698
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 508 WRANGLER DRIVE, SUITE 100
CITY: COPPELL
STATE: TX
ZIP: 75019
BUSINESS PHONE: 650-458-4100
MAIL ADDRESS:
STREET 1: 508 WRANGLER DRIVE, SUITE 100
CITY: COPPELL
STATE: TX
ZIP: 75019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Guillem Alvaro
CENTRAL INDEX KEY: 0001608783
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36489
FILM NUMBER: 15951541
MAIL ADDRESS:
STREET 1: 508 WRANGLER DRIVE, SUITE 100
CITY: COPPELL
STATE: TX
ZIP: 75019
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-18
0
0001459266
ZS Pharma, Inc.
ZSPH
0001608783
Guillem Alvaro
805 VETERANS BLVD, SUITE 300
REDWOOD CITY
CA
94063
0
1
0
0
See Remarks
Employee Stock Options
2015-06-18
4
A
0
37500
55.57
A
Common Stock
37500
37500
D
Restricted Stock Unit
2015-06-18
4
A
0
6500
0.00
A
Common Stock
6500
6500
D
Dr. Guillem was granted an option to purchase 37,500 shares of common stock at an exercise price per share of $55.57 on June 18, 2015, of which 25% of the shares subject to such option will vest on the first anniversary of the date of grant, with the remaining 75% of the shares vesting monthly in substantially equal installments over the following 36 months, subject to Dr. Guillem's continuing to provide services to the company and to the terms of the option agreement accompanying the grant.
On June 18, 2015, Dr. Guillem was granted 6,500 restricted stock units representing the right to receive one share of common stock upon vesting of each restricted stock unit. The restricted stock units vest over four years, with 25% vesting on each of the first four anniversaries of the date of grant, subject to Dr. Guillem's continuing to provide services to the company on each vesting date.
President
/s/ Alvaro F. Guillem
2015-06-25